Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Yau

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
BMJ Open|October 9, 2023
Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocolAnuradhaa Subramanian, Siang Ing Lee, Sudasing Pathirannehelage Buddhika Hemali Sudasinghe, et al.
Nature Communications|June 10, 2022
Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
Nature Communications|February 4, 2018
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
JCI Insight|May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cellsMara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
BMC Medicine|August 22, 2023
The development of a core outcome set for studies of pregnant women with multimorbiditySiang Ing Lee, Stephanie Hanley, Zoe Vowles, et al.
Cancer Cell|August 2, 2016
Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic NicheFabrizio Miranda, David Mannion, Shujuan Liu, et al.
Nature|March 29, 2023
An atlas of genetic scores to predict multi-omic traitsYu Xu, Scott C Ritchie, Yujian Liang, et al.
Ebiomedicine|August 6, 2016
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studiesKarin Hellner, Fabrizio Miranda, Donatien Fotso Chedom, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
BMJ Open|October 9, 2023
Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocolAnuradhaa Subramanian, Siang Ing Lee, Sudasing Pathirannehelage Buddhika Hemali Sudasinghe, et al.
Nature Communications|June 10, 2022
Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
Nature Communications|February 4, 2018
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
JCI Insight|May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cellsMara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
BMC Medicine|August 22, 2023
The development of a core outcome set for studies of pregnant women with multimorbiditySiang Ing Lee, Stephanie Hanley, Zoe Vowles, et al.
Cancer Cell|August 2, 2016
Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic NicheFabrizio Miranda, David Mannion, Shujuan Liu, et al.
Nature|March 29, 2023
An atlas of genetic scores to predict multi-omic traitsYu Xu, Scott C Ritchie, Yujian Liang, et al.
Ebiomedicine|August 6, 2016
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studiesKarin Hellner, Fabrizio Miranda, Donatien Fotso Chedom, et al.
Pageof 9